登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《JAMA，3月9日，Diagnostic Testing for the Novel Coronavirus》

  • 来源专题：COVID-19科研动态监测
  • 编译者： zhangmin
  • 发布时间：2020-03-11

  • Diagnostic Testing for the Novel Coronavirus

    Joshua M. Sharfstein, MD1; Scott J. Becker, MS2; Michelle M. Mello, JD, PhD3

    Author Affiliations Article Information

    JAMA. Published online March 9, 2020. doi:10.1001/jama.2020.3864

    Controversies over diagnostic testing have dominated US headlines about severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the novel coronavirus responsible for coronavirus disease 2019 (COVID-19). Technical challenges with the first test developed by the Centers for Disease Control and Prevention (CDC) left the nation with minimal diagnostic capacity during the first few weeks of the epidemic. The CDC also initially limited access to testing to a narrow group of individuals with known exposure. The delayed discovery of a case of COVID-19 in California, followed quickly by evidence of community transmission in multiple states, revealed the shortcomings of this strategy. In the early stages, COVID-19 has spread beyond the nation’s ability to detect it.

  • 原文来源：https://jamanetwork.com/journals/jama/fullarticle/2762951?resultClick=1
85浏览量
原文链接
相关报告

  • 《Clinical Chemistry，3月12日，Emergence of a Novel Coronavirus Disease (COVID-19) and the Importance of Diagnostic Testing》
    • 来源专题：COVID-19科研动态监测
    • 编译者：xuwenwhlib
    • 发布时间：2020-03-14
    • Emergence of a Novel Coronavirus Disease (COVID-19) and the Importance of Diagnostic Testing: Why Partnership between Clinical Laboratories, Public Health Agencies, and Industry Is Essential to Control the Outbreak Matthew J Binnicker Clinical Chemistry, hvaa071, https://doi.org/10.1093/clinchem/hvaa071 In late December 2019, Chinese health authorities investigated a cluster of atypical pneumonia cases occurring primarily in individuals who had visited a seafood and wet market in Wuhan, Hubei Province, China. Patients reported fever and cough, and most developed chest discomfort and/or respiratory distress, with a diagnosis of pneumonia being made by chest radiographs and/or computed tomographic (CT) scan (1,). After testing for common causes of respiratory infection yielded negative results, unbiased sequencing of bronchoalveolar lavage (BAL) fluid identified a variant beta-coronavirus with nearly 85% sequence homology to that of a bat severe acute respiratory syndrome (SARS)-like coronavirus (CoV) (1,). The virus was subsequently isolated in eukaryotic cell culture, and further characterization showed it to be distinct from SARS-CoV and Middle East respiratory syndrome (MERS)-CoV, with sequence homology of approximately 79% and about 50%, respectively (2,). The variant CoV, which has been named SARS-CoV-2 by the International Committee on Taxonomy of Viruses (3,), represents the seventh CoV to cause disease in humans, and the third CoV since 2003 to cross over from animals to humans and be associated with severe respiratory illness (1). The World Health Organization (WHO) has named the illness caused by SARS-CoV-2 coronavirus disease-2019 (COVID-19).
    37浏览量
    原文链接

  • 《JAMA，3月16日，Self-Service Diagnosis of COVID-19—Ready for Prime Time?》
    • 来源专题：COVID-19科研动态监测
    • 编译者：xuwenwhlib
    • 发布时间：2020-03-17
    • Self-Service Diagnosis of COVID-19—Ready for Prime Time? Shantanu Nundy, MD, MBA1,2; Kavita K Patel, MD, MSHS3 As the world grapples with the novel coronavirus (COVID-19), experts have called for increased access to health care resources, including diagnostic testing, particularly in light of the recent expansion of the Food and Drug Administration’s Emergency Use Authority to make such testing more widely available in the United States.1 Despite rapid expansion, there are significant barriers to testing in ambulatory clinics, emergency departments, and hospitals, which are likely to see a substantial increase in demand. Such access points also pose risks due to overcrowding and nosocomial transmission.
    90浏览量
    原文链接